Advisornet Financial’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-100
| Closed | -$374 | – | 2183 |
|
|
2023
Q4 | $374 | Hold |
100
| – | – | ﹤0.01% | 2180 |
|
|
2023
Q3 | $212 | Hold |
100
| – | – | ﹤0.01% | 2126 |
|
|
2023
Q2 | $476 | Hold |
100
| – | – | ﹤0.01% | 2064 |
|
|
2023
Q1 | $570 | Hold |
100
| – | – | ﹤0.01% | 2039 |
|
|
2022
Q4 | $1.01K | Sell |
100
-370
| -79% | -$3.73K | ﹤0.01% | 1833 |
|
|
2022
Q3 | $11K | Hold |
470
| – | – | ﹤0.01% | 1288 |
|
|
2022
Q2 | $12K | Hold |
470
| – | – | ﹤0.01% | 1278 |
|
|
2022
Q1 | $18K | Hold |
470
| – | – | ﹤0.01% | 1268 |
|
|
2021
Q4 | $27K | Hold |
470
| – | – | ﹤0.01% | 1200 |
|
|
2021
Q3 | $28K | Hold |
470
| – | – | ﹤0.01% | 1151 |
|
|
2021
Q2 | $41K | Hold |
470
| – | – | ﹤0.01% | 1034 |
|
|
2021
Q1 | $39K | Sell |
470
-100
| -18% | -$8.3K | ﹤0.01% | 1004 |
|
|
2020
Q4 | $52K | Buy |
570
+260
| +84% | +$23.7K | ﹤0.01% | 851 |
|
|
2020
Q3 | $12K | Hold |
310
| – | – | ﹤0.01% | 1205 |
|
|
2020
Q2 | $11K | Hold |
310
| – | – | ﹤0.01% | 1260 |
|
|
2020
Q1 | $7K | Buy |
+310
| New | +$7K | ﹤0.01% | 1337 |
|